Skip to main content
. 2022 Apr 14;13(3):e00435-22. doi: 10.1128/mbio.00435-22

FIG 10.

FIG 10

Proposed model of IFI16 control on HCMV-induced metabolic changes. Upon HCMV infection, IFI16 forms an inhibitory complex with the transcription factor ChREBP, thereby downmodulating the expression of GLUT4 and reducing glucose consumption. Furthermore, IFI16-ChREBP cooperation leads to decreased expression of genes involved in HCMV-induced lipogenesis, which leads to impaired lipid synthesis and reduced infectivity of viral particles.